Founded in 2016, CHIGENOVO is a national high-tech enterprise focusing on the development of gene therapy products and clinical genetic diagnosis for genetic eye diseases, and is one of the first ophthalmic gene therapy enterprises in China. CHIGENOVO is committed to gene technology innovation, eradicating genetic eye diseases, and providing "one-stop" solutions for patients with genetic eye diseases.
Read more β
Tired of ads? Enjoy an ad-free experience by signing up.
Unlock unlimited company data
Already a subscriber? Log in.
Our subscriber community includes professionals from these companies:
Similar companies
Tired of ads? Enjoy an ad-free experience by signing up.